Cargando…

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease

Glial cell-line-derived neurotrophic factor (GDNF) is a potent neuroprotective agent in cellular and animal models of Parkinson’s disease (PD). However, CNS delivery of GDNF in clinical trials has proven challenging due to blood-brain barrier (BBB) impermeability, poor diffusion within brain tissue,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cang, Guderyon, Michael J., Li, Yang, Ge, Guo, Bhattacharjee, Anindita, Ballard, Cori, He, Zhixu, Masliah, Eliezer, Clark, Robert A., O’Connor, Jason C., Li, Senlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931095/ https://www.ncbi.nlm.nih.gov/pubmed/31890743 http://dx.doi.org/10.1016/j.omtm.2019.11.013

Ejemplares similares

GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
por: Chen, Cang, et al.
Publicado: (2018)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Mobilization‐based transplantation of young‐donor hematopoietic stem cells extends lifespan in mice
por: Guderyon, Michael J., et al.
Publicado: (2020)

Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease
por: Li, Xiuhua, et al.
Publicado: (2013)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014)

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders
por: Wang, Li, et al.
Publicado: (2023)

Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms
por: Bose, Anindita, et al.
Publicado: (2018)

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
por: Fan, Ching-Hsiang, et al.
Publicado: (2016)

Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
por: Buhusi, Mona, et al.
Publicado: (2016)

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
por: Barker, Roger A., et al.
Publicado: (2020)

Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
por: Tang, Chuan-Xi, et al.
Publicado: (2022)

The GDNF Family: A Role in Cancer?
por: Fielder, Graeme C., et al.
Publicado: (2017)

Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011)

Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice
por: García-Caballero, Cristina, et al.
Publicado: (2018)

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2016)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Hsc70’s trip to the tip
por: Leslie, Mitch
Publicado: (2015)

Thrombopoietin: tickling the HSC's fancy
por: Kim, Ah Ram, et al.
Publicado: (2017)

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Structure of clathrin coat with bound Hsc70 and auxilin: mechanism of Hsc70-facilitated disassembly
por: Xing, Yi, et al.
Publicado: (2010)

Awakening the HSC: Dynamic Modeling of HSC Maintenance Unravels Regulation of the TP53 Pathway and Quiescence
por: Ikonomi, Nensi, et al.
Publicado: (2020)

Mast Cell Repopulating Ability Is Lost During the Transition From Pre-HSC to FL HSC
por: Yoshimoto, Momoko, et al.
Publicado: (2022)

Comparative analysis of the anticoagulant activities and immunogenicity of HSC70 and HSC70(TKD) of Haemaphysalis flava
por: Liu, Yu-Ke, et al.
Publicado: (2022)

Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
por: Luz, Matthias, et al.
Publicado: (2018)

Microglia in Parkinson’s Disease
por: Stefanova, Nadia
Publicado: (2022)

Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson’s Disease
por: Cong, Linlin, et al.
Publicado: (2016)

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
por: Valera, Elvira, et al.
Publicado: (2015)

TGF-β1 Increases GDNF Production by Upregulating the Expression of GDNF and Furin in Human Granulosa-Lutein Cells
por: Yin, Jingwen, et al.
Publicado: (2020)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2018)

Glial cell line-derived neurotrophic factor (GDNF) attenuates the peripheral neuromuscular dysfunction without inhibiting the activation of spinal microglia/monocyte
por: Xie, Fei, et al.
Publicado: (2018)

Lower GDNF Serum Level Is a Possible Risk Factor for Constipation in Patients With Parkinson Disease: A Case–Control Study
por: Chen, Gang, et al.
Publicado: (2022)

Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
por: Tong, Shu-Yan, et al.
Publicado: (2023)

Filgrastim-Associated Pneumonitis in Cancer Patient Undergoing Hematopoietic Stem Cell (HSC) Mobilization for Autologous-HSC Transplantation
por: Patel, Drashti R, et al.
Publicado: (2020)

GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries
por: Cintrón-Colón, Alberto F., et al.
Publicado: (2021)

Astrocytes, Microglia, and Parkinson's Disease
por: Joe, Eun-Hye, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_22ef9tcnio0dttsctpdulgq1bs